LISATA THERAPEUTICS INC (LSTA)

US1280583022 - Common Stock

3.85  +0.28 (+7.84%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
N/AN/A0.000.00-10.00K
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
23.48M25.71M57.60M29.05M19.15M
Research and Development
11.40M12.73M43.46M17.68M9.25M
Selling, General, and Administrative Expenses
12.09M12.97M14.14M11.37M9.89M
Operating Income
-23.48M-25.71M-57.60M-29.05M-19.15M
Interest Income/Expense
2.20M2.72M1.05M150.00KN/A
Other Income/Expense
-257.00K-186.00K-160.00K-80.00K130.00K
Non Recurring Items
N/A0.00N/AN/AN/A
Income Before Taxes
-21.54M-23.17M-56.70M-28.97M-19.01M
Income Tax
-798.00K-2.33M-2.48M-1.51M-10.87M
Net Income
-20.74M-20.84M-54.23M-27.47M-8.15M
EBITDA
-23.30M-25.52M-57.53M-28.99M-19.09M
 
Per Share Data
EPS Diluted Total Ops
-2.51-2.58-10.47-7.45-7.92
Non GAAP EPS
-2.51-2.58-11.34-7.80-6.75
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts